For pharmaceutical CEOs: keep paused autoship subscribers engaged
For pharmaceutical CEOs: keep paused autoship subscribers engaged
CEOs see paused autoship subscribers drop out of recurring revenue, risking subscription churn. Add paused contacts to a win-back list so marketing can re-engage lapsed subscribers before churn.
Overview
Paused autoship subscribers quietly erode recurring revenue for pharmaceutical companies if marketing misses re-engagement windows. This workflow captures every paused contact into a win-back list and notifies marketing, turning passive churn into recoverable opportunities so manual follow-ups stop slipping through.
Notable Features
- Add paused subscribers to win-back list
- Tag contacts for targeted campaigns
- Alert marketing about churn risk